Liver cirrhosis trials in China

In China 75 Also abroad 358

32 of 75 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis
Where
Zhuhai
Age
18 years and over
People
364
Run by
Fifth Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT07920744
No phaseNot yet taking people in China
A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy
Where
Nanjing
Age
18 years to 75 years
People
700
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07612670
No phaseTaking people
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
Where
Wenzhou
Age
18 years and over
People
216
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06316869
No phaseTaking people
Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
Where
Yangzhou
Age
18 years to 80 years
People
30
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07811687
No phaseTaking people
Digital Early Warning System for Acute Lung Injury in Liver Surgery
Where
Beijing, Chongqing, Qingdao
Age
18 years and over
People
3,000
Run by
Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT07070362
No phaseTaking people
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
Where
Hangzhou
Age
65 years to 100 years
People
20,000
Run by
The Affiliated Hospital of Hangzhou Normal University
See details and how to joinNCT07241195
No phaseTaking people
Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Where
Nanjing
Age
18 years and over
People
1,000
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07612163
No phaseNot yet taking people in China
Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism
Where
Yangzhou
Age
18 years to 75 years
People
140
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07490405
No phaseNot yet taking people in China
Effect of Laparoscopic Splenectomy on Renal Function in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
Where
Yangzhou
Age
18 years to 80 years
People
30
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07585773
No phaseNot yet taking people in China
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
Where
Yangzhou
Age
18 years to 80 years
People
30
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07588334
No phaseNot yet taking people in China
Effect of Laparoscopic Splenectomy on Lipid Profiles in Cirrhotic Patients With Hypersplenism (2-Year Follow-Up)
Where
Yangzhou
Age
18 years to 80 years
People
30
Run by
Northern Jiangsu People's Hospital
See details and how to joinNCT07588373
No phaseTaking people
Indicators Affecting PVT Recanalization
Where
Shanghai
Age
18 years to 80 years
People
1,500
Run by
Shanghai Zhongshan Hospital
See details and how to joinNCT07473375
No phaseNot yet taking people in China
Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.
Where
Guangzhou
Age
18 years to 80 years
People
200
Run by
Zhujiang Hospital
See details and how to joinNCT07455175
No phaseNot yet taking people in China
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
Where
Beijing, Hengshui, Qingdao, Qinhuangdao, Shenzhen, Wuxi
Age
18 years and over
People
2,522
Run by
Peking University First Hospital
See details and how to joinNCT07422701
No phaseTaking people
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
Where
Shenyang
Age
18 years to 75 years
People
150
Run by
Shengjing Hospital
See details and how to joinNCT05475015
No phaseTaking people
3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
Where
Shenyang
Age
18 years to 75 years
People
100
Run by
Shengjing Hospital
See details and how to joinNCT06205992
No phaseTaking people
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
Where
Jinan
Age
18 years and over
People
100
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07275554
No phaseTaking people
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
Where
Changsha, Fuzhou, Huanggang, Jingzhou, Nanchang, Nanjing, Shenyang, Taiyuan, Wuhan, Xiangyang, Yichang, Zhengzhou
Age
18 years to 80 years
People
250
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07172035
No phaseTaking people
Risk Assessment for HBV-Related Liver Cancer
Where
Guangzhou
Age
30 years to 75 years
People
6,000
Run by
Sun Yat-sen University
See details and how to joinNCT07160946
No phaseTaking people
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
Where
Hengyang
Age
18 years to 75 years
People
800
Run by
The First Affiliated Hospital of University of South China
See details and how to joinNCT07147335
No phaseTaking people
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
Where
Guangzhou, Shanghai
Age
18 years and over
People
375 worldwide
Run by
Chinese University of Hong Kong
See details and how to joinNCT06549673
No phaseNot yet taking people in China
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
Where
Beijing, Changsha, Changzhi, Foshan, Fuzhou, Guangzhou, Guiyang, Jincheng, Jinzhong, Lanzhou, Nanchang, Nanjing, Qingdao, Shanghai, Shenyang, Shiyan, Taiyuan, Zhuhai
Age
18 years to 75 years
People
735
Run by
Beijing Friendship Hospital
See details and how to joinNCT07087041
No phaseNot yet taking people in China
Prognostic Model for MASLD Related Cirrhosis
Where
Beijing, Tianjin
Age
18 years to 80 years
People
228
Run by
Beijing Friendship Hospital
See details and how to joinNCT07082751
No phaseTaking people
Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Where
Xi'an
Age
18 years to 70 years
People
1,500
Run by
First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT07079150
No phaseTaking people
The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive Models
Where
Chongqing
Age
18 years to 75 years
People
300
Run by
Juan Kang
See details and how to joinNCT06328517